Nebivolol: impact on cardiac and endothelial function and clinical utility
JE Toblli, F DiGennaro, JF Giani… - Vascular Health and …, 2012 - Taylor & Francis
Endothelial dysfunction is a systemic pathological state of the endothelium characterized by
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
Nebivolol: impact on cardiac and endothelial function and clinical utility.
JE Toblli, F DiGennaro, JF Giani… - Vascular Health and Risk …, 2012 - europepmc.org
Endothelial dysfunction is a systemic pathological state of the endothelium characterized by
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
[引用][C] Nebivolol: impact on cardiac and endothelial function and clinical utility
J Toblli, F DiGennaro, FG Jorge, DF Pablo - Vascular Health and Risk …, 2012 - cir.nii.ac.jp
Nebivolol: impact on cardiac and endothelial function and clinical utility | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本を …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本を …
Nebivolol: impact on cardiac and endothelial function and clinical utility
JE Toblli, F DiGennaro, JF Giani… - Vascular Health and Risk …, 2012 - go.gale.com
Endothelial dysfunction is a systemic pathological state of the endothelium characterized by
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
Nebivolol: impact on cardiac and endothelial function and clinical utility
JE Toblli, F DiGennaro, JF Giani, FP Dominici - 2012 - datosdeinvestigacion.conicet.gov.ar
Endothelial dysfunction is a systemic pathological state of the endothelium characterized by
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
[PDF][PDF] Nebivolol: impact on cardiac and endothelial function and clinical utility
JE Toblli - Vascular Health and Risk Management, 2012 - core.ac.uk
Endothelial dysfunction is a systemic pathological state of the endothelium characterized by
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
[HTML][HTML] Nebivolol: impact on cardiac and endothelial function and clinical utility
JE Toblli, F DiGennaro, JF Giani… - Vascular Health and …, 2012 - ncbi.nlm.nih.gov
Endothelial dysfunction is a systemic pathological state of the endothelium characterized by
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
Nebivolol: impact on cardiac and endothelial function and clinical utility
JE Toblli, F DiGennaro, JF Giani… - Vascular Health and Risk …, 2012 - dovepress.com
Endothelial dysfunction is a systemic pathological state of the endothelium characterized by
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
Nebivolol: impact on cardiac and endothelial function and clinical utility
JE Toblli, F DiGennaro, JF Giani, FP Dominici - 2012 - notablesdelaciencia.conicet.gov.ar
Endothelial dysfunction is a systemic pathological state of the endothelium characterized by
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
Nebivolol: impact on cardiac and endothelial function and clinical utility
JE Toblli, F DiGennaro, JF Giani… - Vascular health and …, 2012 - pubmed.ncbi.nlm.nih.gov
Endothelial dysfunction is a systemic pathological state of the endothelium characterized by
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …
a reduction in the bioavailability of vasodilators, essentially nitric oxide, leading to impaired …